Skip to content
MARKETS / NYSE / AGL
NYSE · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · LARGE CAP

agilon health, Inc. AGL

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$5.9B
▼ 2.1% YoY
$-391.3M
$-119.0M
In brief

What this company does

The company operates by primarily forming risk-bearing entities within local geographies that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners' attributed patients, and the risk-bearing entities contract with agilon to perform certain functions and enter into long-term professional service agreements with anchor physician groups, who receive a base compensation rate and share in the savings from improving quality of care and reducing costs. As of December 31, 2025, agilon and its subsidiaries had 856 employees, substantially all of whom were full-time. As of December 31, 2025, the primary care physicians on its platform served approximately 511,000 Medicare Advantage members and 114,000 Medicare fee-for-service beneficiaries through nine Accountable Care Organizations. It has grown to 28 anchor physician groups and 30 geographies as of December 31, 2025. The company was formed in 2016, and it established its inaugural partnership with an anchor physician group in 2017.

Written from the business description in agilon health, inc.'s annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.

Growth
USD 5.9B
Revenue, FY2025 · full 7-year series below
Revenue $B Net income $B
FY2025 · Revenue 5.9 · Net income -0.4
2.5B5.0B2019202020212022202320242025
Compound annual growth
+35.4%
+37.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +37.2% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−7 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -7.8% · Net -6.6%
-10%-20%-30%2019202020212022202320242025
ROE
FY2025 · ROE -83.1%
-50%-100%2019202020212022202320242025

Each USD of equity lost 83 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -119.0
-80M-160M2019202020212022202320242025
Net buybacks $M Dividends $M
FY2023 · Dividends — · Net buybacks 188.1
80M160M-10M-20M20202023

Total assetsUSD 1.3B
CashUSD 173.7M
Gross debtUSD 35.0M
Net debtUSD -138.7M
Current ratio1.02×

Not available: we don't have the shareholders' equity figure for this period.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B5.96.14.32.41.51.20.8
Operating income $B−0.5−0.3−0.2−0.1−0.4−0.1−0.1
EBITDA $B−0.4−0.3−0.2−0.1−0.4−0.0−0.1
Income tax $B0.00.00.00.00.00.0−0.0
Net income $B−0.4−0.3−0.3−0.1−0.4−0.1−0.3
Free cash flow $B−0.1−0.1−0.2−0.1−0.2−0.1−0.1
EPS, diluted $·······
Dividend / sh $·······
Payout %·······
ROE %−83.1−45.9−30.8−10.0−100.7··
Shares out B0.410.410.410.410.400.25·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 19 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 57 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Misc Health & Allied Services, NEC
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image